Tumor Characterization Solutions for Clinical Trials, Cancer Research & Immuno-Oncology

This presentation covers comprehensive tumor characterization solutions for clinical trials, cancer research and immune-oncology, including: specific challenges in sequencing and analyzing tumors for neoantigen identification; key differentiators of the ACE ImmunoID as compared to standard NGS offerings; and a review of the technical performance of the ACE assays, as well as the analytical validation.